Abstract
Methylmercury (MeHg) is a well-known environmental neurotoxin. The choroid plexus (CP), the main component of the blood–cerebrospinal fluid (CSF) barrier (BCSFB), protects the brain from xenobiotics, similar to the blood–brain barrier. Because CP is considered a critical target site of MeHg-induced neurotoxic damage, functional alterations in CP may be caused in relation to the extent of MeHg-induced brain injury. To test this hypothesis, we examined time-dependent pathological alterations in rats administered subtoxic (asymptomatic group) or toxic (symptomatic group) MeHg doses for 3 weeks after the cessation of MeHg administration. We primarily assessed (1) mercury concentrations in the brain, CSF, and plasma; (2) histopathological changes in the brain; (3) albumin CSF/plasma concentration quotient (Qalb), an index of BCSFB dysfunction; and (4) concentration of CSF transthyretin (TTR), which is primarily produced in CP. Mercury concentrations in the brain, CSF, and plasma decreased, and Qalb and CSF TTR concentrations did not change significantly in the asymptomatic group. In the symptomatic group, brain and CSF mercury concentrations did not decrease for 2 weeks after the cessation of MeHg administration, but no pathological alteration occurred in the brain during this period. Pathological changes in the cerebellum became evident 3 weeks after the cessation of MeHg administration. Furthermore, Qalb continued to increase after the cessation of MeHg administration, whereas no decrease in CSF TTR concentration was observed, indicating selective impairment of CP function. These findings suggest that MeHg at toxic doses causes selective functional alteration of CP before leading to pathological alterations in the brain.
Similar content being viewed by others
Abbreviations
- BBB:
-
blood–brain barrier
- BCSFB:
-
blood–CSF barrier
- CNS:
-
central nervous system
- CP:
-
choroid plexus
- CSF:
-
cerebrospinal fluid
- Ct:
-
threshold cycles
- GFAP:
-
glial fibrillary acidic protein
- MeHg:
-
methylmercury
- MUSTag:
-
Multiple Simultaneous Tag
- Qalb :
-
CSF/plasma concentration quotient
- RT-PCR:
-
reverse transcriptase-polymerase chain reaction
- SELDI-TOF–MS:
-
surface-enhanced laser desorption ionization-time-of-flight-mass spectrometry
- TTR:
-
transthyretin
- TUNEL:
-
terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling
References
Andersson M, Alvarez-Cermeño J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Grønning M, Keir G, Lamers K, Link H, Magalhães A, Massaro AR, Öhman S, Reiber H, Rönnbäck L, Schluep M, Schuller E, Sindic CJM, Thompson EJ, Trojano M, Wurster U (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57: 897–902
Bradbury MW (1984) The structure and function of the blood-brain barrier. Fed Proc 43:186–190
Broadwell RD, Sofroniew MV (1993) Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp Neurol 120:245–263
Choi BH (1989) The effects of methylmercury on the developing brain. Prog Neurobiol 32:447–470
Clarkson TW (1997) The toxicology of mercury. Crit Rev Clin Lab Sci 34:369–403
Clarkson TW, Magos L, Myers GJ (2003) The toxicology of mercury—current exposures and clinical manifestations. N Engl J Med 349:1731–1737
Dickson PW, Aldred AR, Marley PD, Tu GF, Howlett GJ, Schreiber G (1985) High prealbumin and transferring mRNA levels in the choroid plexus of rat brain. Biochem Biophys Res Commun 127:890–895
Eto K (2000) Minamata disease. Neuropathology 20:S14–S19
Herbert J, Wilcox JN, Pham KT, Fremeau RT Jr, Zeviani M, Dwork A, Soprano DR, Makover A, Goodman DS, Zimmerman EA, Roberts JL, Schon E (1986) Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 36:900–911
Ingenbleek Y, Young V (1994) Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 14:495–533
Johanson CE (1995) Ventricles and cerebrospinal fluid. In: Conn MP (ed) Neuroscience in medicine. Lippincott, Philadelphia, pp 171–196
Johanson CE, Duncan JA 3rd, Klinge PM, Brinker T, Stopa EG, Silverberg GD (2008) Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 5:10
Møller-Madsen B (1991) Localization of mercury in CNS of the rat. III. Oral administration of methylmercuric chloride (CH3HgCl). Fundam Appl Toxicol 16:172–187
Mori N, Yasutake A, Hirayama K (2007) Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Arch Toxicol 81:769–776
Ohkawa T, Uenoyama H, Tanida K, Ohmae T (1977) Ultra trace mercury analysis by dry thermal decomposition in alumina porcelain tube. J Hyg Chem 23:13–22
Pardridge WM (1988) Recent advances in blood-brain barrier transport. Annu Rev Pharmacol Toxicol 28:25–39
Reiber H (1997) CSF flow—its influence on CSF concentration of brain-derived and blood derived proteins. In: Teelken A, Korf J (eds) Neurochemistry. Plenum, New York, pp 423–432
Reiber H (2001) Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310:173–186
Sakai K (1975) Time-dependent distribution of 203Hg-methylmercuric chloride in tissues and cells of rats. Jpn J Exp Med 45:63–77
Schreiber G, Aldred AR, Jaworowski A, Nilsson C, Achen MG, Segal MB (1990) Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol 258:R338–R345
Shibasaki F, Morizane Y, Ishikawa Y, Makisaka N, Komata Y, Chen L, Uchida K (2008) Clinical application of supersensitive and multiplex assay, MUSTag technology. Rinsho Byori 56:802–810
Strazielle N, Ghersi-Egea JF (1999) Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 19:6275–6289
Strazielle N, Ghersi-Egea JF (2000) Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol 59:561–574
Suda I, Eto K, Tokunaga H, Furusawa R, Suetomi K, Takahashi H (1989) Different histochemical findings in the brain produced by mercuric chloride and methyl mercury chloride in rats. Neurotoxicology 10:113–125
Takeuchi T, Eto K, Tokunaga H (1989) Mercury level and histochemical distribution in a human brain with Minamata disease following a long-term clinical course of twenty-six years. Neurotoxicology 10:651–657
Tokuomi H, Okajima T, Kanai J, Tsunoda M, Ichiyasu Y, Misumi H, Shimomura K, Takaba M (1961) Minamata disease—an unusual neurological disorder occurring in Minamata, Japan. Kumamoto Med J 14:47–64
Wojtczak A (1997) Crystal structure of rat transthyretin at 2.5 A resolution: first report on a unique tetrameric structure. Acta Biochim Pol 44:505–517
Yasutake A, Hirayama K (1986) Strain difference in mercury excretion in methylmercury-treated mice. Arch Toxicol 59:99–102
Yasutake A, Hirayama K, Inoue M (1989) Mechanism of urinary excretion of methylmercury in mice. Arch Toxicol 63:479–483
Yasutake A, Nakano A, Hirayama K (1998) Induction by mercury compounds of brain metallothionein in rats: HgO exposure induces long-lived brain metallothionein. Arch Toxicol 72:187–191
Zheng W, Perry DF, Nelson DL, Aposhian HV (1991) Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB J 5:2188–2193
Acknowledgments
The authors thank Ms. N. Tabata, Ms. M. Ogata, and Ms. A. Onitsuka for their technical assistance in various analyses. The experimental protocol was approved by the Ethics Committee for Research on Animals at the National Institute for Minamata Disease.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, M., Yasutake, A., Fujimura, M. et al. Effect of methylmercury administration on choroid plexus function in rats. Arch Toxicol 85, 911–918 (2011). https://doi.org/10.1007/s00204-010-0623-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-010-0623-8